The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.

On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]

Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."



Contacts

Jeff Wurzburg
Jeff Wurzburg
Partner
Email
jeff.wurzburg@nortonrosefulbright.com
T: +1 210 270 9338
Vanessa Grant
Vanessa Grant
Senior Partner
Email
vanessa.grant@nortonrosefulbright.com
T: +1 416 216 4056

Practice areas:

Industry:

Recent publications

A doctor in a whitecoat holding a tablet in a hospital hallway

Publication

FTC continues enforcement focus on non-competes

The FTC has continued its focus on antitrust issues.

United States | September 18, 2025

Healthcare
CMS issues interim rule addressing Medicaid disenrollments effective immediately

Publication

CMS clarifies budget reconciliation bill ahead of rulemaking

The Centers for Medicare and Medicaid Services issued guidance on September 9, 2025, preliminarily implementing Section 71116 of the budget reconciliation bill, known as the ‘One Big Beautiful Bill Act’.

United States | September 16, 2025

Healthcare
Masters of Taste

Publication

AB 2499 brings new notice duties for California employers

The California Civil Rights Department published a model notice.

United States | September 12, 2025

Employment and labor
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now